Fortrea Holdings Inc. (FTRE)

Market Cap	724.31M
Revenue (ttm)	2.70B
Net Income (ttm)	-328.50M
Shares Out	90.20M
EPS (ttm)	-3.67
PE Ratio	n/a
Forward PE	16.09
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,752,133
Open	8.27
Previous Close	8.36
Day's Range	7.99 - 8.38
52-Week Range	8.00 - 40.63
Beta	n/a
Analysts	Hold
Price Target	20.30 (+152.8%)
Earnings Date	Mar 3, 2025

About FTRE

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical services that provides development and consulting services to clinical pharmacology and clinical development spectrum. The company also offers delivery models that include full service, functional service provider, and hybrid service structures. In addition, it delivers phase I – IV clinical trial management, clinical phar...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1996
• Employees: 16,120
• Stock Exchange: NASDAQ
• Ticker Symbol: FTRE
• Website: https://www.fortrea.com

Financial Performance

In 2024, Fortrea Holdings's revenue was $2.70 billion, a decrease of -5.14% compared to the previous year's $2.84 billion. Losses were -$328.50 million, 1203.6% more than in 2023.

Analyst Forecast

According to 11 analysts, the average rating for FTRE stock is "Hold." The 12-month stock price forecast is $20.3, which is an increase of 152.80% from the latest price.

Price Target

$20.3

(152.80% upside)

Analyst Consensus: Hold